1. Volume 57, Issue 2, Pages 590-600 (October 2000)
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients 
Juliana C.N. Chan, Gary T.C. Ko, Denis H.Y. Leung, Robert C.K. Cheung, Margaret Y.F. Cheung, Wing-Yee So, Ramasmyiyer Swaminathan, M. Gary Nicholls, Julian A.J.H. Critchley, Clive S. Cockram 
Kidney International 
Volume 57, Issue 2, Pages (October 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Rates of deterioration of renal function, expressed as 24-hour creatinine clearance, in hypertensive type 2 diabetic patients, subdivided into normoalbuminuric (•), microalbuminuric (▪), and macroalbuminuric (▴) groups based on two of three 24-hour urinary albumin excretion measurements at baseline.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Effects of enalapril (□) and nifedipinetreatment on progression of renal function, expressed as regression coefficient of yearly plasma creatinine reciprocal (β-1/Cr) in hypertensive type 2 diabetic patients subdivided into normoalbuminuric, microalbuminuric, and macroalbuminuric groups based on two of three 24-hour urinary albumin excretion measurements at baseline.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions